Clinical Trials Browser

Interventional × Has results × Tablets × Clear all

NCT04544995 2026-01-21

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

Phase 1 Terminated

47 enrolled 43 charts

Neoplasms, Neuroblastoma, Osteosarcoma

NCT04456920 2025-12-02

BIO-PSY

Phase NA Completed

193 enrolled 19 charts

Breast Neoplasms

NCT04233034 2024-11-27

CLVer

Phase 3 Completed

113 enrolled 42 charts

Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT05258747 2024-10-03

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Phase 1 Completed

70 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04393454 2024-07-25

Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

Phase 2 Terminated

6 enrolled 12 charts

Neoplasm Metastasis, Neoplasms

NCT03027557 2021-05-25

DENOCINA

Phase 3 Completed

46 enrolled 49 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Phase 1 Completed

168 enrolled 59 charts

GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01865747 2021-04-27

METEOR

Phase 3 Completed

658 enrolled 15 charts

Carcinoma, Renal Cell

NCT01827930 2020-12-31

MIM

Phase 3 Terminated

68 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT00748189 2019-06-25

COMPLEMENT 1

Phase 3 Terminated

447 enrolled 32 charts

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00723398 2018-11-01

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Phase NA Completed

266 enrolled 20 charts

Breast Neoplasms

NCT00703508 2017-06-14

Pharmacogenetics of Metformin Action in PCOS

Phase NA Completed

55 enrolled 7 charts

Polycystic Ovary Syndrome

NCT01943864 2017-05-31

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

Phase 2 Completed

20 enrolled 27 charts

Gastrointestinal

Biliary Tract Neoplasms, Neoplasms

NCT00941863 2016-03-22

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Phase 1 Completed

158 enrolled 17 charts

Carcinoma

NCT01563055 2015-08-10

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

10 enrolled 52 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01808326 2015-06-22

A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

5 enrolled 23 charts

Other hematologic neoplasm

Leukemia